XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 19, 2023
USD ($)
Batch
Apr. 01, 2019
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Term
Facility
Center
Jun. 30, 2022
USD ($)
Dec. 31, 2021
Facility
Vendor and Licensor Commitments [Abstract]              
Number of FDA-licensed plasma collection facilities approved | Facility         6    
Number of FDA Inspections | Facility             2
Non recurring charge of inventory $ 2,100,000            
Impact of operating expenses $ 700,000   $ 1,333,424 $ 3,921,486 $ 3,113,887 $ 7,896,075  
Number of batches in production at the time of disruption | Batch 2            
Plasma supply agreement term         10 years    
Plasma purchased from Grifols         $ 5,200,000 $ 22,800,000  
Percentage of inventory purchases         26.00% 66.00%  
Post-Marketing Commitments [Abstract]              
Research and Development Expense   $ 1,500,000 $ 1,403,260 $ 873,386 $ 2,258,611 $ 1,497,497  
BIVIGAM [Member]              
Post-Marketing Commitments [Abstract]              
Research and Development Expense         1,400,000 900,000  
ASCENIV [Member]              
Post-Marketing Commitments [Abstract]              
Research and Development Expense         $ 400,000 $ 200,000  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | International Customers [Member]              
Vendor and Licensor Commitments [Abstract]              
Concentration risk, percentage         7.00% 7.00%  
Maximum [Member]              
Vendor and Licensor Commitments [Abstract]              
IT technology systems inaccessible period 7 days            
2011 Plasma Purchase Agreement [Member]              
Vendor and Licensor Commitments [Abstract]              
Plasma purchase agreement term         10 years    
Number of renewal terms | Term         2    
Plasma purchase agreement renewal period         5 years    
Number of plasma collection centers that collects RSV Plasma which were transferred to BPC | Center         2    
Percentage of plasma purchase price equal to cost         5.00%    
2011 Plasma Purchase Agreement [Member] | Maximum [Member]              
Vendor and Licensor Commitments [Abstract]              
Number of plasma collection facilities | Facility         5    
2017 Plasma Purchase Agreement [Member]              
Vendor and Licensor Commitments [Abstract]              
Number of plasma collection facilities | Facility         10    
Plasma purchase agreement term         5 years    
Number of renewal terms | Term         2    
Plasma purchase agreement renewal period         2 years